Spiegelman Daniel K
SEC-identified person · CIK 1238403 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| vTv Therapeutics Inc. VTVT | Director | filed 2024 - 2026 |
| Maze Therapeutics, Inc. MAZE | Director | filed 2025 - 2026 |
| Spruce Biosciences, INC. SPRB | Director | filed 2020 - 2026 |
| Kyverna Therapeutics, Inc. KYTX | Director | filed 2024 - 2025 |
| Myriad Genetics INC MYGN | Director | filed 2020 - 2024 |
| Jiya Acquisition Corp. JYAC | Director | filed 2020 - 2020 |
| Biomarin Pharmaceutical INC BMRN | EVP, Chief Financial Officer | filed 2012 - 2019 |
| Oncothyreon Inc. ONTY | Director | filed 2008 - 2018 |
| Relypsa Inc RLYP | Director | filed 2014 - 2016 |
| Anthera Pharmaceuticals Inc ANTH | Director | filed 2010 - 2014 |
| Affymax INC AFFY | Director | filed 2006 - 2012 |
| Omeros Corp OMER | Director | filed 2009 - 2012 |
| Xcyte Therapies INC XYCT | Director | filed 2006 - 2012 |
| CV Therapeutics INC CVTX | SVP, CFO | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.